The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets

Frontiers Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma

Nontargeted and targeted metabolomics approaches reveal the key amino acid alterations involved in multiple myeloma [PeerJ]

Publications - RMG Registry

Multiple myeloma Leaders in Pharmaceutical Business Intelligence

Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling

Histone deacetylase inhibitor LMK-235-mediated HO-1 expression induces apoptosis in multiple myeloma cells via the JNK/AP-1 signaling pathway - ScienceDirect

Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ

Selective antisense oligonucleotide inhibition of human IRF4

Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy. - Abstract - Europe PMC

Frontiers Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy

Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma

Haematologica, Volume 106, Issue 7 by Haematologica - Issuu

人磷脂酰乙醇胺结合蛋白4在多发性骨髓瘤中的表达及其意义

Understanding endometriosis from an immunomicroenvironmental